• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质干细胞中 P53 功能异常促进骨肉瘤的发展。

P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.

机构信息

Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University, School of Medicine, 320 Yueyang Road, Shanghai 200031, China.

Biochemistry Laboratory IDI-IRCC, Department of Experimental Medicine and Surgery, University of Rome Torvergata, Rome 00133, Italy.

出版信息

Cell Death Dis. 2016 Jan 21;7(1):e2015. doi: 10.1038/cddis.2015.367.

DOI:10.1038/cddis.2015.367
PMID:26775693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4816167/
Abstract

It has been shown that p53 has a critical role in the differentiation and functionality of various multipotent progenitor cells. P53 mutations can lead to genome instability and subsequent functional alterations and aberrant transformation of mesenchymal stem cells (MSCs). The significance of p53 in safeguarding our body from developing osteosarcoma (OS) is well recognized. During bone remodeling, p53 has a key role in negatively regulating key factors orchestrating the early stages of osteogenic differentiation of MSCs. Interestingly, changes in the p53 status can compromise bone homeostasis and affect the tumor microenvironment. This review aims to provide a unique opportunity to study the p53 function in MSCs and OS. In the context of loss of function of p53, we provide a model for two sources of OS: MSCs as progenitor cells of osteoblasts and bone tumor microenvironment components. Standing at the bone remodeling point of view, in this review we will first explain the determinant function of p53 in OS development. We will then summarize the role of p53 in monitoring MSC fidelity and in regulating MSC differentiation programs during osteogenesis. Finally, we will discuss the importance of loss of p53 function in tissue microenvironment. We expect that the information provided herein could lead to better understanding and treatment of OS.

摘要

已经表明,p53 在各种多能祖细胞的分化和功能中起着关键作用。p53 突变可导致基因组不稳定,随后导致间充质干细胞(MSCs)的功能改变和异常转化。p53 对于保护我们的身体免受骨肉瘤(OS)的发展的重要性是众所周知的。在骨重塑过程中,p53 在负调控调控 MSC 成骨分化早期的关键因子中起着关键作用。有趣的是,p53 状态的变化会破坏骨内稳态并影响肿瘤微环境。这篇综述旨在提供一个研究 p53 在 MSCs 和 OS 中的功能的独特机会。在 p53 功能丧失的情况下,我们为两种 OS 来源提供了一个模型:作为成骨细胞祖细胞的 MSC 和骨肿瘤微环境成分。从骨重塑的角度来看,在这篇综述中,我们将首先解释 p53 在 OS 发展中的决定性功能。然后,我们将总结 p53 在监测 MSC 保真度和调节成骨过程中的 MSC 分化程序中的作用。最后,我们将讨论 p53 功能丧失在组织微环境中的重要性。我们期望本文提供的信息可以帮助我们更好地理解和治疗 OS。

相似文献

1
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.间质干细胞中 P53 功能异常促进骨肉瘤的发展。
Cell Death Dis. 2016 Jan 21;7(1):e2015. doi: 10.1038/cddis.2015.367.
2
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.骨环境对于转化的间充质干细胞发展成骨肉瘤至关重要。
Stem Cells. 2014 May;32(5):1136-48. doi: 10.1002/stem.1647.
3
Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.间质干细胞中 p53 的缺失通过负向调控护骨素促进骨重塑的改变。
Cell Death Differ. 2021 Jan;28(1):156-169. doi: 10.1038/s41418-020-0590-4. Epub 2020 Jul 21.
4
Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.在人骨髓间充质干细胞中,通过 Rb 失活和 c-Myc 过表达的组合生成骨肉瘤。
Stem Cells Transl Med. 2017 Feb;6(2):512-526. doi: 10.5966/sctm.2015-0226. Epub 2016 Sep 7.
5
Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.骨肉瘤来源的细胞外囊泡对间充质干细胞的表观遗传改变。
Epigenetics. 2019 Apr;14(4):352-364. doi: 10.1080/15592294.2019.1585177. Epub 2019 Mar 24.
6
Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy.间充质干细胞和细胞外囊泡在骨肉瘤发病机制和治疗中的作用。
Int J Mol Sci. 2021 Oct 13;22(20):11035. doi: 10.3390/ijms222011035.
7
CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.间质干细胞衍生的白细胞介素-8 诱导的 CXCR1/Akt 信号激活促进骨肉瘤细胞的失巢凋亡抵抗和肺转移。
Cell Death Dis. 2018 Jun 18;9(7):714. doi: 10.1038/s41419-018-0745-0.
8
Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway.骨肉瘤细胞通过 TGF-β/Smad2/3 通路抑制间充质干细胞的成骨分化,从而促进其产生促肿瘤细胞因子。
Exp Cell Res. 2014 Jan 1;320(1):164-73. doi: 10.1016/j.yexcr.2013.10.013. Epub 2013 Oct 30.
9
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.骨肉瘤起源于间充质干细胞,是由于非整倍体和 Cdkn2 的基因组缺失所致。
J Pathol. 2009 Nov;219(3):294-305. doi: 10.1002/path.2603.
10
The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.p53-Rb 缺陷型骨髓间充质干细胞的分化阶段赋予体内肉瘤发展的表型。
Oncogene. 2013 Oct 10;32(41):4970-80. doi: 10.1038/onc.2012.507. Epub 2012 Dec 10.

引用本文的文献

1
MEF2C is a potential prognostic biomarker for osteosarcoma.MEF2C是骨肉瘤的一种潜在预后生物标志物。
Medicine (Baltimore). 2025 Sep 5;104(36):e44313. doi: 10.1097/MD.0000000000044313.
2
Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma.人类与犬骨肉瘤中差异表达基因的比较
Life (Basel). 2025 Jun 12;15(6):951. doi: 10.3390/life15060951.
3
SNX10 in autosomal recessive osteosclerosis, osteosarcoma, rheumatoid arthritis, and osteoporosis: molecular mechanisms and therapeutic implications.常染色体隐性骨硬化症、骨肉瘤、类风湿性关节炎和骨质疏松症中的分选连接蛋白10:分子机制及治疗意义

本文引用的文献

1
The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.p53四聚体显示出其C末端结构域与DNA结合结构域之间的诱导契合相互作用。
Oncogene. 2016 Jun 23;35(25):3272-81. doi: 10.1038/onc.2015.388. Epub 2015 Oct 19.
2
p63 supports aerobic respiration through hexokinase II.p63通过己糖激酶II支持有氧呼吸。
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11577-82. doi: 10.1073/pnas.1508871112. Epub 2015 Aug 31.
3
KMT Set7/9 affects genotoxic stress response via the Mdm2 axis.赖氨酸甲基转移酶Set7/9通过Mdm2轴影响基因毒性应激反应。
Front Cell Dev Biol. 2025 Jun 10;13:1602240. doi: 10.3389/fcell.2025.1602240. eCollection 2025.
4
The Hippo pathway in bone and cartilage: implications for development and disease.骨骼与软骨中的河马信号通路:对发育和疾病的影响
PeerJ. 2025 Apr 22;13:e19334. doi: 10.7717/peerj.19334. eCollection 2025.
5
Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential.靶向p53-p21信号通路以增强间充质干细胞的再生潜能。
Regen Ther. 2025 Apr 7;29:352-363. doi: 10.1016/j.reth.2025.03.007. eCollection 2025 Jun.
6
Change in p53 nuclear localization in response to extracellular matrix stiffness.p53核定位响应细胞外基质硬度的变化。
Smart Med. 2024 Nov 17;3(4):e20240026. doi: 10.1002/SMMD.20240026. eCollection 2024 Dec.
7
E3 ubiquitin ligases: key regulators of osteogenesis and potential therapeutic targets for bone disorders.E3泛素连接酶:成骨作用的关键调节因子及骨疾病的潜在治疗靶点。
Front Cell Dev Biol. 2024 Aug 15;12:1447093. doi: 10.3389/fcell.2024.1447093. eCollection 2024.
8
Osteogenic Protection against Fine Dust with Erucic Acid-Induced Exosomes.芥酸诱导的外泌体对细颗粒物的成骨保护作用
J Funct Biomater. 2024 Jul 31;15(8):215. doi: 10.3390/jfb15080215.
9
Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach.肠道微生物代谢产物在治疗骨质疏松症和肥胖症中的潜力:网络药理学和生物信息学方法。
Med Sci Monit. 2024 Mar 10;30:e942899. doi: 10.12659/MSM.942899.
10
The p53-mediated cell cycle regulation is a potential mechanism for emodin-suppressing osteosarcoma cells.p53介导的细胞周期调控是大黄素抑制骨肉瘤细胞的一种潜在机制。
Heliyon. 2024 Feb 23;10(5):e26850. doi: 10.1016/j.heliyon.2024.e26850. eCollection 2024 Mar 15.
Oncotarget. 2015 Sep 22;6(28):25843-55. doi: 10.18632/oncotarget.4584.
4
The 26S proteasome is a multifaceted target for anti-cancer therapies.26S蛋白酶体是抗癌疗法的一个多方面的靶点。
Oncotarget. 2015 Sep 22;6(28):24733-49. doi: 10.18632/oncotarget.4619.
5
How Does p73 Cause Neuronal Defects?p73如何导致神经元缺陷?
Mol Neurobiol. 2016 Sep;53(7):4509-20. doi: 10.1007/s12035-015-9381-1. Epub 2015 Aug 13.
6
Maintaining epithelial stemness with p63.维持上皮干细胞干性的 p63。
Sci Signal. 2015 Jul 28;8(387):re9. doi: 10.1126/scisignal.aaa1033.
7
Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.去甲氯米帕明对肺癌干细胞的抗肿瘤作用。
Oncotarget. 2015 Jul 10;6(19):16926-38. doi: 10.18632/oncotarget.4700.
8
Genome-editing tools for stem cell biology.用于干细胞生物学的基因组编辑工具。
Cell Death Dis. 2015 Jul 23;6(7):e1831. doi: 10.1038/cddis.2015.167.
9
Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.Δ122p53(Δ133p53α的一种小鼠模型)增强了一种弱化型p53突变体的肿瘤抑制活性。
Cell Death Dis. 2015 Jun 11;6(6):e1783. doi: 10.1038/cddis.2015.149.
10
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression.p53 家族与缺氧诱导因子(HIFs):癌症进展的决定因素。
Trends Biochem Sci. 2015 Aug;40(8):425-34. doi: 10.1016/j.tibs.2015.04.007. Epub 2015 May 29.